Proliferation imaging to measure early cancer response to targeted therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19010830.
- Also identified by DOI 10.1158/1078-0432.CCR-08-2233.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Positron emission tomography imaging using thymidine and analogues labeled with positron emitters provides noninvasive and quantitative estimates of regional cellular proliferation. This CCR Translations summary reviews the biological basis for proliferation imaging and discusses recent results using 18F-fluorothymidine-positron emission tomography to measure response to targeted therapy in the context of prior studies and potential future applications.
Medical subject headings
- Neoplasms
- Positron-Emission Tomography
- Radiopharmaceuticals